ratio

(redirected from benefit-risk ratio)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.

Ratio

The division of one piece of financial information by another. Financial ratios are very common in fundamental analysis, which investigates the financial health of companies. An example of a financial ratio is the price-earnings ratio, which divides a publicly-traded company's share price by its earnings per share. This and other ratios help analysts determine whether a company's share price properly reflects its performance.

ratio

The relation between two quantities when compared mathematically with one another. For example, the most frequently used ratio among investors is the price-earnings ratio. Financial analysts, investors, and managers use ratios to evaluate many factors such as the attractiveness of a stock or the operating efficiency of a company. Also called financial ratio. See also activity ratio, debt management ratio, liquidity ratio, profitability ratio.
References in periodicals archive ?
But all patients with chronic or rare diseases know that the benefit-risk ratio for any new drug or device is an important consideration," said Diane Dorman, NORD's vice president of public policy.
The report was precipitated by two recent clinical trials -- the Women's Health Initiative (WHI) and the Heart and Estrogen/progestin Replacement Study (HERS) -- providing new knowledge that has altered the benefit-risk ratio for postmenopausal hormone therapy use, especially in women at risk for coronary heart disease (CHD).
As part of the analysis that Specialty Pharmaceuticals submitted to the FDA, the company specifically evaluated the benefit-risk ratio of therapy with CONCERTA(R).
The clinical trials -- the Women's Health Initiative (WHI) and the Heart and Estrogen/progestin Replacement Study (HERS) -- provided new knowledge that has altered the benefit-risk ratio for postmenopausal hormone therapy use, especially in women at risk for coronary heart disease (CHD).
2001 NAMS/Ortho-McNeil Pharmaceutical Research Award -- Recognizes contributions to the understanding of issues surrounding the benefit-risk ratio associated with the use of combined estrogen and progestogen therapy in peri- and postmenopausal women: R.